Trials / Unknown
UnknownNCT02996838
A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics
Phase I Study of Tolerance and Pharmacokinetics of TQ-B3234 in Patients With Advanced Cancer
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To study the pharmacokinetic characteristics of TQ-B3234 in the human body, recommend a reasonable regimen for subsequent research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQ-B3234 | TQ-B3234 p.o. qd |
Timeline
- Start date
- 2017-05-11
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2016-12-19
- Last updated
- 2019-05-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02996838. Inclusion in this directory is not an endorsement.